Opioid receptors in GtoPdb v.2021.3

Authors

  • Anna Borsodi Hungarian Academy Of Sciences
  • Michael Bruchas Washington University
  • Girolamo Caló University of Padova
  • Charles Chavkin University of Washington Sch Med
  • MacDonald J. Christie University of Sydney
  • Olivier Civelli University of California, Irvine
  • Mark Connor Macquarie University https://orcid.org/0000-0003-2538-2001
  • Brian M. Cox Uniformed Services University
  • Lakshmi A. Devi Mount Sinai School of Medicine
  • Christopher Evans University of California Los Angeles
  • Volker Höllt Otto-von-Guericke University
  • Graeme Henderson University of Bristol
  • Stephen Husbands University of Bath
  • Eamonn Kelly University of Bristol
  • Brigitte Kieffer Université de Strasbourg
  • Ian Kitchen University of Surrey
  • Mary-Jeanne Kreek Rockefeller University
  • Lee-Yuan Liu-Chen Temple University
  • Dominique Massot Université de Strasbourg
  • Jean-Claude Meunier Institute of Pharmacology and Structural Biology
  • Philip S. Portoghese University of Minnesota
  • Stefan Schulz Friedrich Schiller University
  • Toni S. Shippenberg National Institutes of Health
  • Eric J. Simon New York University
  • Lawrence Toll Florida Atlantic University
  • John R. Traynor University of Michigan
  • Hiroshi Ueda Nagasaki Univ Grad Biomed Sci
  • Yung H. Wong Hong Kong University of Science and Technology
  • Nurulain Zaveri Astraea Therapeutics, LLC
  • Andreas Zimmer University of Bonn

DOI:

https://doi.org/10.2218/gtopdb/F50/2021.3

Abstract

Opioid and opioid-like receptors are activated by a variety of endogenous peptides including [Met]enkephalin (met), [Leu]enkephalin (leu), β-endorphin (β-end), α-neodynorphin, dynorphin A (dynA), dynorphin B (dynB), big dynorphin (Big dyn), nociceptin/orphanin FQ (N/OFQ); endomorphin-1 and endomorphin-2 are also potential endogenous peptides. The Greek letter nomenclature for the opioid receptors, μ, δ and κ, is well established, and NC-IUPHAR considers this nomenclature appropriate, along with the symbols spelled out (mu, delta, and kappa), and the acronyms, MOP, DOP, and KOP. [121, 100, 91]. The human N/OFQ receptor, NOP, is considered 'opioid-related' rather than opioid because, while it exhibits a high degree of structural homology with the conventional opioid receptors [294], it displays a distinct pharmacology. Currently there are numerous clinically used drugs, such as morphine and many other opioid analgesics, as well as antagonists such as naloxone, however only for the μ receptor.

Published

02-Sep-2021

Issue

Section

Summaries

How to Cite

“Opioid receptors in GtoPdb v.2021.3” (2021) IUPHAR/BPS Guide to Pharmacology CITE, 2021(3). doi:10.2218/gtopdb/F50/2021.3.